David G Aliabadi, MD
Cardiovascular Disease (Cardiology) · Thousand Oaks
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 37 years
- University of California, Geffen School of Medicine, 1989
Offices
1 location
Hospitals listed: Los Robles Hospital & Medical Center · Northridge Hospital Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Aliabadi’s office at (805) 480-2600 to ask if they take your plan before you enroll.
California Medical Board record
Licence G69896 · Current
Licensed to practise in California · since 1990 · expires 2028-07-31 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Los Robles Hospital & Medical CenterThousand Oaks, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Northridge Hospital Medical CenterNorthridge, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.11, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.147, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.173, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Los Robles Hospital & Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.84 (0 to 1.7) · 2,135 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.83 (0.56 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 194.58 (150.2 to 238.96) · 162 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 76 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 183 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.3 · 251 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.7 · 535 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 970 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 352 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 4,468 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.33) · 12,215 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.03 to 0.38) · 12,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3 (1.28 to 4.71) · 3,156 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.29 (0 to 2.81) · 1,553 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.74 (0.42 to 3.07) · 3,078 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.59 (6.22 to 16.96) · 1,658 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.29 (2.13 to 8.45) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.51 (0.09 to 2.92) · 825 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.1 (0 to 0.64) · 9,549 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 208 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.763 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.621 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.855 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.744 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 239 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.3 · 502 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 6.9 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -7.5 · 623 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31 · 1,042 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 939 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 197 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.3 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.7 to 17) · 361 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 718 cases | No different | Jan 2024 – Dec 2024 |
What patients said (682 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 65% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for Northridge Hospital Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.11 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.147 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.173 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.13 to 2.13) · 1,012 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.78 (0.44 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.43 (96.43 to 190.42) · 88 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 216 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 457 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.4 · 384 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 315 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 3,091 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.05 to 0.44) · 6,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 6,139 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,225 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.24) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.28 to 3.34) · 1,193 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.26 (0 to 15.07) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.14 (2.11 to 10.16) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.14) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.76) · 5,578 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 139 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 1.041 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 368 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 674 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 27.2 · 214 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.2 · 563 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 23.8 · 438 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 484 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.1 to 7.4) · 44 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.9 (6.8 to 13.8) · 44 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 166 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.9 · 57 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 141 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 165 cases | No different | Jan 2024 – Dec 2024 |
What patients said (621 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$1,376,239
Medicare paid this office $1,376,239 for 2,076 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 262 | $344,998 | $1,312 |
| Return visit (30+ min) | 1,782 | $296,477 | $99 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 262 | $210,185 | $400 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 804 | $150,657 | $164 |
| Short return visit (20+ min) | 882 | $92,288 | $71 |
See all 25 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 262 | $344,998 | $1,312 |
| Return visit (30+ min) | 1,782 | $296,477 | $99 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 262 | $210,185 | $400 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 804 | $150,657 | $164 |
| Short return visit (20+ min) | 882 | $92,288 | $71 |
| Ultrasound of both sides of head and neck blood flow | 434 | $70,051 | $160 |
| New patient visit (60+ min) | 218 | $34,714 | $159 |
| Long return visit (40+ min) | 230 | $34,353 | $138 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 494 | $32,620 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,889 | $28,538 | $11 |
| Programming of dual lead pacemaker system | 156 | $20,755 | $65 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 43 | $16,699 | $380 |
| Injection, regadenoson, 0.1 mg | 267 | $7,446 | None |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 43 | $6,707 | $76 |
| Evaluation of cardiac rhythm monitor system | 26 | $6,424 | $41 |
| Short return visit | 68 | $3,998 | $46 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 178 | $3,528 | $18 |
| Ultrasound scan of abdominal aorta | 23 | $2,694 | $117 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 178 | $2,073 | $11 |
| Programming of dual lead implantable defibrillator system | 13 | $1,571 | $79 |
| Programming of multiple lead implantable defibrillator system | 15 | $1,546 | $77 |
| Ultrasound of heart, follow-up | 15 | $1,474 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,394 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,362 | $62 |
| Limited ultrasound scan behind abdominal cavity | 12 | $614 | $51 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
Who their Medicare patients are
2,076 Original Medicare patients in 2024. Average age 78 · Under 65 1% · 85 and older 18% · Women 55% · Also on Medicaid 4% · Health risk score 1.22. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 44% · Atrial fibrillation 29% · Diabetes 28% · Chronic kidney disease 24% · Cancer 19% · Depression 18% · Stroke 17% · Heart failure 16% · COPD 14% · Dementia 6%.
The office billed $3,623,336, Medicare allowed $1,798,867 and paid $1,376,239; for 12,326 services of 39 kinds; $7,446 of it was for drugs given in the office and $1,368,793 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,076 | 12,326 | 78 | 1.22 | $3,623,336 | $1,376,239 |
| 2023 | 2,147 | 11,932 | 78 | 1.21 | $3,308,449 | $1,347,278 |
| 2022 | 2,182 | 12,029 | 77 | 1.14 | $2,664,360 | $1,058,979 |
| 2021 | 2,000 | 11,529 | 78 | 1.20 | $2,599,648 | $1,081,467 |
| 2020 | 1,686 | 9,183 | 77 | 1.35 | $2,109,843 | $839,992 |
| 2019 | 1,932 | 9,590 | 78 | 1.49 | $2,323,020 | $857,652 |
| 2018 | 1,364 | 7,280 | 77 | 1.37 | $1,883,411 | $691,218 |
| 2017 | 1,255 | 6,731 | 77 | 1.38 | $1,656,451 | $628,750 |
| 2016 | 1,409 | 7,335 | 77 | 1.53 | $1,787,953 | $684,578 |
| 2015 | 1,624 | 6,927 | 78 | 1.63 | $1,597,383 | $620,919 |
| 2014 | 1,541 | 6,356 | 78 | 1.58 | $1,412,015 | $559,019 |
| 2013 | 1,690 | 6,850 | 77 | 1.64 | $1,545,581 | $567,063 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 26 services
| Return visit (30+ min) | 1,805 | $299,256 | $99 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 212 | $287,152 | $1,342 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 217 | $178,073 | $407 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 666 | $125,053 | $171 |
| Ultrasound of both sides of head and neck blood flow | 463 | $77,747 | $167 |
| Short return visit (20+ min) | 700 | $76,593 | $74 |
| New patient visit (60+ min) | 264 | $42,811 | $162 |
| Long return visit (40+ min) | 260 | $40,640 | $147 |
| Injection, regadenoson, 0.1 mg | 230 | $37,625 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,832 | $26,946 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 375 | $24,519 | $62 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 55 | $22,003 | $393 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 103 | $20,267 | $197 |
| Programming of dual lead pacemaker system | 132 | $14,657 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 80 | $13,470 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 104 | $12,390 | $98 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 55 | $8,536 | $76 |
| Evaluation of cardiac rhythm monitor system | 20 | $5,900 | $41 |
| Ultrasound of heart blood flow, valves and chambers | 106 | $4,833 | $46 |
| Short return visit | 81 | $4,662 | $47 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 210 | $4,322 | $19 |
| Ultrasound scan of abdominal aorta | 33 | $4,037 | $122 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 210 | $2,495 | $11 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,437 | $143 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 106 | $2,299 | $22 |
| Ultrasound of heart, follow-up | 14 | $1,344 | $79 |
2022: 29 services
| Return visit (30+ min) | 1,794 | $381,040 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 572 | $107,626 | $171 |
| Ultrasound of both sides of head and neck blood flow | 533 | $91,988 | $171 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 209 | $86,965 | $416 |
| New patient visit (60+ min) | 396 | $66,084 | $167 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 300 | $62,904 | $209 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 209 | $36,260 | $87 |
| Long return visit (40+ min) | 221 | $35,579 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 159 | $34,404 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,780 | $25,985 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 172 | $18,877 | $85 |
| Short return visit (20+ min) | 195 | $16,758 | $73 |
| Injection, regadenoson, 0.1 mg | 87 | $16,735 | None |
| Ultrasound of heart blood flow, valves and chambers | 300 | $14,166 | $47 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 224 | $14,100 | $63 |
| Programming of dual lead pacemaker system | 137 | $8,992 | $33 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $8,945 | $163 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 300 | $6,752 | $22 |
| Ultrasound scan of abdominal aorta | 40 | $5,038 | $126 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 150 | $3,191 | $20 |
| Short return visit | 47 | $2,278 | $45 |
| Evaluation of cardiac rhythm monitor system | 22 | $2,229 | $18 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 150 | $2,074 | $13 |
| External shock to heart to regulate heart beat | 18 | $1,932 | $92 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,540 | $91 |
| Programming of multiple lead implantable defibrillator system | 13 | $1,025 | $54 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 36 | $775 | $22 |
| Heart muscle strain imaging | 14 | $532 | $35 |
| Heart rhythm recording of continous external ekg over 8-15 days | 35 | $446 | $13 |
2021: 31 services
| Return visit (30+ min) | 1,600 | $355,653 | $105 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 285 | $127,271 | $443 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 587 | $115,155 | $180 |
| Ultrasound of both sides of head and neck blood flow | 478 | $87,083 | $182 |
| New patient visit (60+ min) | 531 | $86,182 | $162 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 285 | $50,879 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 184 | $44,901 | $60 |
| Long return visit (40+ min) | 235 | $38,994 | $152 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,613 | $25,936 | $12 |
| Injection, regadenoson, 0.1 mg | 103 | $19,695 | None |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 110 | $18,812 | $171 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 292 | $18,788 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 152 | $17,432 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $13,688 | $169 |
| Ultrasound scan of abdominal aorta | 63 | $8,112 | $129 |
| Short return visit (20+ min) | 82 | $6,997 | $79 |
| Programming of dual lead pacemaker system | 121 | $6,857 | $30 |
| Ultrasound of heart blood flow, valves and chambers | 137 | $6,714 | $49 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 27 | $5,962 | $221 |
| Ultrasound of heart | 115 | $4,167 | $35 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 137 | $3,224 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 110 | $2,724 | $25 |
| External shock to heart to regulate heart beat | 19 | $2,621 | $94 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 81 | $1,707 | $21 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 68 | $1,668 | $23 |
| Short return visit | 29 | $1,451 | $50 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 81 | $1,167 | $14 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,122 | $51 |
| Heart rhythm recording of continous external ekg over 8-15 days | 68 | $1,036 | $14 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $921 | $84 |
| Evaluation of cardiac rhythm monitor system | 12 | $897 | $15 |
2020: 27 services
| Return visit (30+ min) | 1,150 | $217,926 | $86 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 311 | $137,512 | $435 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 485 | $93,647 | $181 |
| Ultrasound of both sides of head and neck blood flow | 363 | $65,399 | $180 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 311 | $55,720 | $88 |
| New patient visit (60+ min) | 310 | $52,907 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 172 | $37,409 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,174 | $21,178 | $14 |
| Long return visit (40+ min) | 168 | $20,867 | $117 |
| Injection, regadenoson, 0.1 mg | 110 | $20,761 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 317 | $18,020 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 130 | $14,575 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $14,171 | $171 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 73 | $12,606 | $168 |
| Ultrasound scan of abdominal aorta | 91 | $11,861 | $130 |
| Ultrasound of heart | 238 | $8,576 | $34 |
| Short return visit (20+ min) | 86 | $5,745 | $63 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 25 | $4,825 | $186 |
| Ultrasound of heart blood flow, valves and chambers | 73 | $3,686 | $49 |
| Programming of dual lead pacemaker system | 69 | $3,639 | $32 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $3,010 | $232 |
| External ekg recording for more than 48 hours up to 21 days | 100 | $2,433 | $24 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 100 | $2,259 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 73 | $1,824 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 73 | $1,753 | $23 |
| Short return visit | 30 | $704 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $270 | $18 |
2019: 28 services
| Return visit (30+ min) | 1,075 | $200,434 | $83 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 371 | $156,019 | $417 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 490 | $91,831 | $173 |
| Ultrasound of both sides of head and neck blood flow | 417 | $71,975 | $171 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 371 | $61,784 | $83 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 139 | $41,001 | $190 |
| Ultrasound of heart | 730 | $29,913 | $36 |
| New patient visit (60+ min) | 190 | $29,802 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 150 | $28,048 | $58 |
| Injection, regadenoson, 0.1 mg | 131 | $23,684 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 377 | $20,044 | $52 |
| Long return visit (40+ min) | 163 | $19,536 | $111 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 897 | $15,966 | $13 |
| Ultrasound scan of abdominal aorta | 98 | $12,159 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 127 | $12,088 | $83 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 71 | $10,819 | $152 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,376 | $162 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $3,861 | $215 |
| Ultrasound of heart blood flow, valves and chambers | 71 | $3,252 | $46 |
| Programming of dual lead pacemaker system | 63 | $2,963 | $26 |
| Short return visit | 66 | $2,545 | $37 |
| External ekg recording for more than 48 hours up to 21 days | 95 | $2,200 | $23 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 95 | $2,043 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 71 | $1,609 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 71 | $1,565 | $22 |
| Short return visit (20+ min) | 15 | $938 | $59 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 21 | $359 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 34 | $232 | $7 |
2018: 24 services
| Return visit (30+ min) | 1,028 | $179,267 | $79 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 344 | $145,140 | $419 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 478 | $87,024 | $172 |
| Ultrasound of both sides of head and neck blood flow | 364 | $61,988 | $169 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 345 | $56,473 | $81 |
| New patient visit (60+ min) | 202 | $30,887 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 148 | $28,529 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 358 | $18,847 | $52 |
| Long return visit (40+ min) | 131 | $16,023 | $110 |
| Injection, regadenoson, 0.1 mg | 92 | $16,004 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 584 | $9,826 | $13 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 46 | $7,819 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $7,079 | $80 |
| Ultrasound of heart | 171 | $6,105 | $35 |
| Programming of dual lead pacemaker system | 67 | $3,126 | $27 |
| New patient visit (45+ min) | 24 | $3,067 | $128 |
| Ultrasound of heart blood flow, valves and chambers | 46 | $2,139 | $46 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 46 | $1,042 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 46 | $1,037 | $23 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 14 | $1,010 | $72 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 44 | $962 | $21 |
| Short return visit (20+ min) | 16 | $880 | $49 |
| External ekg recording for more than 48 hours up to 21 days | 22 | $512 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $211 | $18 |
2017: 26 services
| Return visit (30+ min) | 948 | $176,420 | $78 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 301 | $125,131 | $410 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 400 | $80,237 | $186 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 301 | $49,313 | $81 |
| Ultrasound of both sides of head and neck blood flow | 260 | $43,399 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 152 | $31,973 | $56 |
| New patient visit (60+ min) | 157 | $24,143 | $154 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 311 | $17,498 | $55 |
| Injection, regadenoson, 0.1 mg | 89 | $15,486 | None |
| Long return visit (40+ min) | 101 | $12,186 | $110 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 46 | $9,179 | $200 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 471 | $7,615 | $13 |
| New patient visit (45+ min) | 44 | $4,835 | $110 |
| Ultrasound of heart | 127 | $4,586 | $35 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $4,140 | $207 |
| Programming of dual lead pacemaker system | 70 | $3,409 | $27 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 43 | $2,990 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,218 | $158 |
| Ultrasound of heart blood flow, valves and chambers | 46 | $2,099 | $46 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $2,040 | $82 |
| Short return visit (20+ min) | 18 | $1,362 | $57 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 46 | $1,179 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 46 | $1,010 | $22 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 17 | $332 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $227 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 21 | $119 | $6 |
2016: 27 services
| Return visit (30+ min) | 881 | $177,198 | $80 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 325 | $138,305 | $420 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 402 | $80,578 | $189 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 325 | $56,306 | $86 |
| Ultrasound of both sides of head and neck blood flow | 237 | $40,382 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 133 | $32,315 | $57 |
| New patient visit (60+ min) | 198 | $31,896 | $161 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 341 | $19,544 | $56 |
| Injection, regadenoson, 0.1 mg | 102 | $17,162 | None |
| Long return visit (40+ min) | 89 | $10,582 | $111 |
| Ultrasound of heart | 294 | $10,441 | $33 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 510 | $9,555 | $14 |
| Short return visit (20+ min) | 129 | $9,439 | $59 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 35 | $7,810 | $217 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $6,533 | $163 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 31 | $6,264 | $202 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $5,864 | $489 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 55 | $3,910 | $71 |
| Programming of dual lead pacemaker system | 66 | $3,488 | $29 |
| New patient visit (45+ min) | 22 | $2,856 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $1,760 | $80 |
| Ultrasound of heart blood flow, valves and chambers | 31 | $1,459 | $47 |
| External shock to heart to regulate heart beat | 14 | $1,374 | $98 |
| Initial hospital care with same-day admission and discharge with straightforward or low level of medical decision making, per day at least 45 minutes | 11 | $1,185 | $108 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 31 | $819 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 121 | $748 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $701 | $23 |
2015: 28 services
| Return visit (30+ min) | 728 | $149,491 | $83 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 297 | $129,574 | $430 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 334 | $69,510 | $196 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 297 | $52,439 | $87 |
| Ultrasound of both sides of head and neck blood flow | 209 | $36,864 | $176 |
| New patient visit (60+ min) | 150 | $25,036 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 122 | $23,698 | $59 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 319 | $18,803 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 93 | $17,048 | $161 |
| Injection, regadenoson, 0.1 mg | 94 | $15,948 | None |
| Ultrasound of heart | 376 | $15,661 | $37 |
| Short return visit (20+ min) | 165 | $12,743 | $56 |
| Long return visit (40+ min) | 71 | $8,638 | $115 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 380 | $7,223 | $14 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 30 | $6,892 | $209 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,398 | $492 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 554 | $3,972 | $7 |
| Programming of dual lead pacemaker system | 64 | $3,664 | $29 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 17 | $3,494 | $206 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $2,011 | $74 |
| Initial hospital care with same-day admission and discharge with straightforward or low level of medical decision making, per day at least 45 minutes | 12 | $1,534 | $110 |
| External shock to heart to regulate heart beat | 11 | $1,416 | $101 |
| External ekg recording for more than 48 hours up to 21 days | 37 | $905 | $24 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 37 | $834 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 17 | $817 | $48 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 17 | $457 | $27 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $399 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $268 | $18 |
2014: 23 services
| Return visit (30+ min) | 650 | $133,095 | $85 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 269 | $118,247 | $438 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 302 | $63,290 | $200 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 269 | $46,735 | $87 |
| Ultrasound of both sides of head and neck blood flow | 162 | $28,082 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 123 | $27,710 | $60 |
| Short return visit (20+ min) | 244 | $19,316 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 292 | $18,038 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $17,186 | $167 |
| New patient visit (60+ min) | 105 | $17,144 | $163 |
| Ultrasound of heart | 279 | $11,637 | $36 |
| Injection, regadenoson, 0.1 mg | 67 | $10,980 | None |
| Long return visit (40+ min) | 63 | $7,604 | $117 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $5,970 | $221 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 311 | $5,821 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 699 | $5,341 | $7 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 16 | $3,486 | $218 |
| Programming of dual lead pacemaker system | 60 | $3,059 | $29 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 38 | $2,724 | $72 |
| Initial hospital care with same-day admission and discharge with straightforward or low level of medical decision making, per day at least 45 minutes | 13 | $1,399 | $108 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $785 | $49 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 15 | $407 | $27 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $380 | $24 |
2013: 26 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 297 | $137,400 | $453 |
| Return visit (30+ min) | 596 | $115,482 | $84 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 310 | $54,352 | $165 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 297 | $52,323 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 132 | $28,607 | $59 |
| Short return visit (20+ min) | 268 | $22,615 | $57 |
| Ultrasound of both sides of head and neck blood flow | 126 | $21,091 | $167 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 317 | $20,059 | $61 |
| New patient visit (60+ min) | 125 | $19,466 | $156 |
| Ultrasound of heart | 350 | $15,195 | $37 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $12,882 | $161 |
| Injection, regadenoson, 0.1 mg | 72 | $12,154 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 895 | $7,800 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 37 | $7,799 | $200 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $6,684 | $446 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 295 | $5,660 | $15 |
| Long return visit (40+ min) | 42 | $4,724 | $112 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 58 | $4,529 | $75 |
| Initial hospital care with same-day admission and discharge with straightforward or low level of medical decision making, per day at least 45 minutes | 30 | $3,412 | $107 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 17 | $2,631 | $155 |
| Programming of dual lead pacemaker system | 50 | $2,214 | $26 |
| Evaluation of heart function using tilt table | 12 | $924 | $77 |
| Ultrasound of heart blood flow, valves and chambers | 17 | $686 | $40 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 17 | $525 | $31 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $311 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $178 | $16 |
Medicaid work
$3,073 in 2021
Medicaid paid $3,073 for 27 billed services this clinician did in 2021, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 27 | $3,073 |
| 2021 | 27 | 1 | 14 | $3,073 |
| 2020 | 12 | 1 | 12 | $997 |
| 2019 | 60 | 2 | 17 | $3,243 |
See the largest Medicaid services in earlier years
2020
| Return visit (30+ min) | 12 | $997 |
2019
| ECHO TRANSTHORAC R-T 2D W/WO M-MODE REC COMP | 47 | $2,162 |
| Return visit (30+ min) | 13 | $1,081 |
Drugs they prescribed that Part D paid
$2,146,666
Pharmacies billed $2,146,666 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 10,473) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
8,676 generic and 1,797 brand-name prescriptions · $2,146,666 in drug cost · 53 antibiotic prescriptions to 32 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 602 | $702,130 | $1,166 |
| Repatha Sureclick | 429 | $476,458 | $1,111 |
| Xarelto | 165 | $225,770 | $1,368 |
| Entresto | 132 | $164,526 | $1,246 |
| Farxiga | 74 | $87,657 | $1,185 |
See all 89 drugs
| Eliquis | 602 | $702,130 | $1,166 |
| Repatha Sureclick | 429 | $476,458 | $1,111 |
| Xarelto | 165 | $225,770 | $1,368 |
| Entresto | 132 | $164,526 | $1,246 |
| Farxiga | 74 | $87,657 | $1,185 |
| Multaq | 34 | $50,808 | $1,494 |
| Vascepa | 57 | $42,772 | $750 |
| Corlanor | 13 | $24,475 | $1,883 |
| Coreg Cr | 13 | $17,149 | $1,319 |
| Nexletol | 14 | $15,664 | $1,119 |
| Norvasc | 13 | $15,455 | $1,189 |
| Praluent | 20 | $13,507 | $675 |
| Icosapent Ethyl | 42 | $11,791 | $281 |
| Metoprolol | 680 | $11,652 | $17 |
| Nexlizet | 17 | $10,457 | $615 |
| Ranolazine Er | 52 | $7,664 | $147 |
| Flecainide Acetate | 107 | $7,455 | $70 |
| Ezetimibe | 319 | $7,193 | $23 |
| Atorvastatin | 831 | $6,993 | $8 |
| Edarbi | 11 | $6,468 | $588 |
| Losartan | 569 | $6,461 | $11 |
| Amlodipine Besylate | 702 | $6,400 | $9 |
| Rosuvastatin | 565 | $6,238 | $11 |
| Valsartan | 155 | $4,490 | $29 |
| Midodrine | 45 | $4,274 | $95 |
| Nebivolol | 48 | $3,883 | $81 |
| Propranolol Hcl Er | 28 | $3,598 | $128 |
| Hydrochlorothiazide | 533 | $3,232 | $6 |
| Metoprolol | 398 | $3,199 | $8 |
| Carvedilol | 322 | $3,089 | $10 |
| Nifedipine Er | 50 | $2,705 | $54 |
| Nitroglycerin Patch | 41 | $2,669 | $65 |
| Simvastatin | 348 | $2,617 | $8 |
| Amiodarone | 71 | $2,490 | $35 |
| Nitroglycerin | 83 | $2,168 | $26 |
| Lisinopril | 245 | $2,158 | $9 |
| Valsartan-Hydrochlorothiazide | 88 | $2,123 | $24 |
| Toprol Xl | 13 | $2,051 | $158 |
| Diltiazem 24hr Er (Cd) | 70 | $1,989 | $28 |
| Propafenone | 22 | $1,966 | $89 |
| Potassium Chloride | 95 | $1,688 | $18 |
| Clopidogrel | 143 | $1,649 | $12 |
| Olmesartan Medoxomil | 72 | $1,551 | $22 |
| Fenofibrate | 39 | $1,321 | $34 |
| Atenolol | 133 | $1,173 | $9 |
| Furosemide | 219 | $1,096 | $5 |
| Ramipril | 89 | $1,023 | $11 |
| Warfarin | 100 | $1,004 | $10 |
| Digoxin | 45 | $989 | $22 |
| Losartan-Hydrochlorothiazide | 53 | $954 | $18 |
| Levothyroxine | 55 | $869 | $16 |
| Spironolactone | 97 | $810 | $8 |
| Sotalol | 26 | $732 | $28 |
| Pravastatin | 46 | $728 | $16 |
| Triamterene-Hydrochlorothiazid | 50 | $673 | $13 |
| Doxazosin Mesylate | 36 | $672 | $19 |
| Diltiazem | 50 | $653 | $13 |
| Omega-3 Acid Ethyl Esters | 13 | $616 | $47 |
| Benazepril | 29 | $616 | $21 |
| Bisoprolol-Hydrochlorothiazide | 35 | $550 | $16 |
| Propranolol | 21 | $547 | $26 |
| Bisoprolol | 27 | $442 | $16 |
| Allopurinol | 23 | $441 | $19 |
| Irbesartan | 37 | $435 | $12 |
| Sumatriptan | 12 | $417 | $35 |
| Tamsulosin | 21 | $388 | $18 |
| Escitalopram | 13 | $373 | $29 |
| Omeprazole | 24 | $365 | $15 |
| Fludrocortisone Acetate | 17 | $358 | $21 |
| Verapamil Er | 12 | $334 | $28 |
| Isosorbide Mononitrate Er | 22 | $328 | $15 |
| Enalapril Maleate | 18 | $325 | $18 |
| Montelukast | 20 | $279 | $14 |
| Lisinopril-Hydrochlorothiazide | 26 | $263 | $10 |
| Bumetanide | 19 | $256 | $13 |
| Finasteride | 11 | $231 | $21 |
| Chlorthalidone | 16 | $188 | $12 |
| Alprazolam | 30 | $174 | $6 |
| Clonidine | 25 | $162 | $6 |
| Lovastatin | 23 | $142 | $6 |
| Metformin Hcl Er | 17 | $132 | $8 |
| Amlodipine Besylate-Benazepril | 12 | $124 | $10 |
| Zolpidem | 22 | $108 | $5 |
| Trazodone | 14 | $108 | $8 |
| Famotidine | 25 | $64 | $3 |
| Metformin | 12 | $52 | $4 |
| Amoxicillin | 37 | $50 | $1 |
| Hydralazine | 11 | $41 | $4 |
| Fluoxetine | 12 | $23 | $2 |
Year by year
| 2024 | 10,473 | 1,337 | 0% (0) | 17% | $2,146,666 |
| 2023 | 10,032 | 1,283 | None | None | $2,301,362 |
| 2022 | 10,394 | 1,268 | None | None | $1,979,676 |
| 2021 | 9,412 | 1,203 | None | 17% | $1,531,710 |
| 2020 | 7,463 | 884 | 0% (0) | 18% | $1,088,762 |
| 2019 | 6,781 | 750 | 0% (0) | None | $942,564 |
| 2018 | 5,833 | 700 | None | None | $706,736 |
| 2017 | 5,402 | 610 | 0% (0) | 21% | $618,431 |
| 2016 | 5,322 | 560 | None | None | $551,683 |
| 2015 | 4,646 | 476 | None | None | $460,523 |
| 2014 | 4,410 | 455 | None | None | $398,283 |
| 2013 | 4,304 | 385 | None | None | $347,144 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 90 drugs
| Eliquis | 528 | $675,671 | $1,280 |
| Repatha Sureclick | 461 | $564,362 | $1,224 |
| Xarelto | 186 | $264,278 | $1,421 |
| Entresto | 103 | $162,503 | $1,578 |
| Vascepa | 60 | $56,138 | $936 |
| Farxiga | 35 | $52,554 | $1,502 |
| Multaq | 31 | $49,575 | $1,599 |
| Corlanor | 15 | $31,456 | $2,097 |
| Praluent | 22 | $23,494 | $1,068 |
| Metoprolol | 713 | $17,759 | $25 |
| Ezetimibe | 340 | $15,482 | $46 |
| Nexlizet | 18 | $12,991 | $722 |
| Coreg Cr | 15 | $12,118 | $808 |
| Rosuvastatin | 461 | $10,934 | $24 |
| Ranolazine Er | 51 | $10,072 | $197 |
| Atorvastatin | 802 | $9,713 | $12 |
| Nexletol | 18 | $9,532 | $530 |
| Midodrine | 39 | $8,254 | $212 |
| Losartan | 504 | $7,356 | $15 |
| Amlodipine Besylate | 767 | $7,250 | $9 |
| Icosapent Ethyl | 16 | $6,628 | $414 |
| Valsartan | 157 | $6,276 | $40 |
| Hydrochlorothiazide | 550 | $4,297 | $8 |
| Nifedipine Er | 55 | $4,150 | $75 |
| Nebivolol | 41 | $4,065 | $99 |
| Altace | 13 | $3,883 | $299 |
| Flecainide Acetate | 72 | $3,759 | $52 |
| Valsartan-Hydrochlorothiazide | 94 | $3,742 | $40 |
| Diltiazem 24hr Er (Cd) | 56 | $3,649 | $65 |
| Carvedilol | 289 | $3,644 | $13 |
| Metoprolol | 361 | $3,608 | $10 |
| Simvastatin | 347 | $3,408 | $10 |
| Amiodarone | 73 | $2,674 | $37 |
| Olmesartan Medoxomil | 59 | $2,522 | $43 |
| Nitroglycerin Patch | 33 | $2,497 | $76 |
| Lisinopril | 233 | $2,474 | $11 |
| Cozaar | 11 | $2,435 | $221 |
| Potassium Chloride | 72 | $2,391 | $33 |
| Propranolol Hcl Er | 21 | $2,312 | $110 |
| Clopidogrel | 150 | $2,268 | $15 |
| Nitroglycerin | 60 | $2,017 | $34 |
| Toprol Xl | 14 | $2,002 | $143 |
| Warfarin | 93 | $1,506 | $16 |
| Irbesartan | 44 | $1,506 | $34 |
| Digoxin | 41 | $1,471 | $36 |
| Losartan-Hydrochlorothiazide | 62 | $1,457 | $24 |
| Atenolol | 142 | $1,448 | $10 |
| Diltiazem | 34 | $1,369 | $40 |
| Propafenone | 20 | $1,359 | $68 |
| Ramipril | 76 | $1,161 | $15 |
| Omega-3 Acid Ethyl Esters | 15 | $1,129 | $75 |
| Fenofibrate | 37 | $1,125 | $30 |
| Furosemide | 155 | $1,088 | $7 |
| Pravastatin | 58 | $1,013 | $17 |
| Spironolactone | 90 | $1,010 | $11 |
| Levothyroxine | 52 | $949 | $18 |
| Sotalol | 24 | $941 | $39 |
| Bisoprolol | 33 | $927 | $28 |
| Bisoprolol-Hydrochlorothiazide | 37 | $920 | $25 |
| Propranolol | 26 | $859 | $33 |
| Triamterene-Hydrochlorothiazid | 60 | $831 | $14 |
| Enalapril Maleate | 21 | $799 | $38 |
| Dofetilide | 12 | $688 | $57 |
| Verapamil Er | 11 | $627 | $57 |
| Tamsulosin | 23 | $531 | $23 |
| Metolazone | 16 | $483 | $30 |
| Allopurinol | 20 | $476 | $24 |
| Escitalopram | 14 | $431 | $31 |
| Sumatriptan | 15 | $428 | $29 |
| Telmisartan | 15 | $382 | $25 |
| Famotidine | 22 | $377 | $17 |
| Omeprazole | 29 | $374 | $13 |
| Dilt-Xr | 12 | $368 | $31 |
| Montelukast | 18 | $347 | $19 |
| Benazepril | 23 | $329 | $14 |
| Isosorbide Mononitrate Er | 16 | $311 | $19 |
| Clonidine | 37 | $309 | $8 |
| Fluoxetine | 28 | $292 | $10 |
| Zolpidem | 34 | $291 | $9 |
| Hydralazine | 12 | $271 | $23 |
| Alprazolam | 31 | $250 | $8 |
| Lisinopril-Hydrochlorothiazide | 23 | $224 | $10 |
| Finasteride | 13 | $215 | $17 |
| Doxazosin Mesylate | 14 | $211 | $15 |
| Lovastatin | 16 | $169 | $11 |
| Trazodone | 11 | $133 | $12 |
| Pantoprazole | 14 | $130 | $9 |
| Sertraline | 11 | $98 | $9 |
| Amoxicillin | 41 | $95 | $2 |
| Metformin Hcl Er | 12 | $42 | $3 |
2022: 90 drugs
| Eliquis | 513 | $591,135 | $1,152 |
| Repatha Sureclick | 416 | $419,169 | $1,008 |
| Xarelto | 196 | $258,141 | $1,317 |
| Entresto | 80 | $123,746 | $1,547 |
| Vascepa | 55 | $49,094 | $893 |
| Multaq | 27 | $37,953 | $1,406 |
| Ezetimibe | 423 | $26,883 | $64 |
| Nexlizet | 32 | $21,142 | $661 |
| Metoprolol | 727 | $19,608 | $27 |
| Praluent | 17 | $17,852 | $1,050 |
| Icosapent Ethyl | 27 | $15,647 | $580 |
| Norvasc | 11 | $14,933 | $1,358 |
| Nexletol | 19 | $12,402 | $653 |
| Ranolazine Er | 43 | $10,422 | $242 |
| Rosuvastatin | 402 | $10,008 | $25 |
| Nebivolol | 48 | $8,726 | $182 |
| Atorvastatin | 822 | $8,719 | $11 |
| Brilinta | 11 | $8,625 | $784 |
| Valsartan | 156 | $8,219 | $53 |
| Amlodipine Besylate | 732 | $7,796 | $11 |
| Midodrine | 25 | $6,929 | $277 |
| Losartan | 535 | $6,846 | $13 |
| Coreg Cr | 14 | $6,081 | $434 |
| Valsartan-Hydrochlorothiazide | 95 | $5,942 | $63 |
| Bystolic | 13 | $4,396 | $338 |
| Nifedipine Er | 48 | $4,266 | $89 |
| Hydrochlorothiazide | 554 | $4,092 | $7 |
| Carvedilol | 277 | $4,032 | $15 |
| Simvastatin | 389 | $3,888 | $10 |
| Flecainide Acetate | 63 | $3,742 | $59 |
| Propranolol Hcl Er | 35 | $3,466 | $99 |
| Metoprolol | 448 | $3,385 | $8 |
| Olmesartan Medoxomil | 67 | $3,353 | $50 |
| Amiodarone | 105 | $2,964 | $28 |
| Toprol Xl | 22 | $2,949 | $134 |
| Fenofibrate | 39 | $2,943 | $75 |
| Clopidogrel | 183 | $2,905 | $16 |
| Nitroglycerin Patch | 45 | $2,862 | $64 |
| Losartan-Hydrochlorothiazide | 80 | $2,796 | $35 |
| Altace | 12 | $2,715 | $226 |
| Nitroglycerin | 66 | $2,663 | $40 |
| Diltiazem 24hr Er (Cd) | 68 | $2,658 | $39 |
| Lisinopril | 266 | $2,284 | $9 |
| Potassium Chloride | 79 | $2,281 | $29 |
| Atenolol | 165 | $2,177 | $13 |
| Cozaar | 12 | $1,884 | $157 |
| Propafenone | 14 | $1,583 | $113 |
| Diltiazem | 28 | $1,540 | $55 |
| Digoxin | 39 | $1,534 | $39 |
| Irbesartan | 42 | $1,471 | $35 |
| Warfarin | 122 | $1,454 | $12 |
| Ramipril | 66 | $1,389 | $21 |
| Furosemide | 175 | $1,309 | $7 |
| Levothyroxine | 58 | $1,278 | $22 |
| Pravastatin | 50 | $1,124 | $22 |
| Bisoprolol-Hydrochlorothiazide | 38 | $1,059 | $28 |
| Propranolol | 22 | $1,035 | $47 |
| Omega-3 Acid Ethyl Esters | 12 | $1,033 | $86 |
| Doxazosin Mesylate | 22 | $969 | $44 |
| Dofetilide | 11 | $954 | $87 |
| Spironolactone | 100 | $933 | $9 |
| Triamterene-Hydrochlorothiazid | 62 | $917 | $15 |
| Enalapril Maleate | 32 | $870 | $27 |
| Bumetanide | 13 | $745 | $57 |
| Omeprazole | 38 | $698 | $18 |
| Bisoprolol | 31 | $674 | $22 |
| Allopurinol | 24 | $575 | $24 |
| Benazepril | 37 | $547 | $15 |
| Sumatriptan | 14 | $508 | $36 |
| Escitalopram | 22 | $464 | $21 |
| Lisinopril-Hydrochlorothiazide | 30 | $444 | $15 |
| Hydralazine | 14 | $418 | $30 |
| Telmisartan | 11 | $407 | $37 |
| Alprazolam | 42 | $399 | $9 |
| Dilt-Xr | 12 | $392 | $33 |
| Pantoprazole | 25 | $353 | $14 |
| Lovastatin | 21 | $344 | $16 |
| Tamsulosin | 18 | $335 | $19 |
| Isosorbide Mononitrate Er | 18 | $327 | $18 |
| Diltiazem 24hr Er | 11 | $312 | $28 |
| Metformin | 20 | $309 | $15 |
| Famotidine | 19 | $299 | $16 |
| Montelukast | 15 | $290 | $19 |
| Clonidine | 29 | $289 | $10 |
| Trazodone | 13 | $223 | $17 |
| Zolpidem | 41 | $210 | $5 |
| Sotalol | 17 | $206 | $12 |
| Quinapril | 12 | $185 | $15 |
| Fluoxetine | 19 | $103 | $5 |
| Amoxicillin | 33 | $70 | $2 |
2021: 89 drugs
| Eliquis | 466 | $453,309 | $973 |
| Xarelto | 200 | $242,059 | $1,210 |
| Repatha Sureclick | 291 | $222,456 | $764 |
| Entresto | 36 | $55,546 | $1,543 |
| Vascepa | 64 | $47,613 | $744 |
| Multaq | 23 | $35,239 | $1,532 |
| Brilinta | 43 | $33,007 | $768 |
| Bystolic | 63 | $27,504 | $437 |
| Praluent | 43 | $25,644 | $596 |
| Ezetimibe | 351 | $23,272 | $66 |
| Betapace | 12 | $21,798 | $1,817 |
| Metoprolol | 649 | $17,452 | $27 |
| Nexletol | 21 | $13,606 | $648 |
| Nexlizet | 22 | $9,314 | $423 |
| Atorvastatin | 713 | $8,453 | $12 |
| Valsartan | 116 | $7,484 | $65 |
| Rosuvastatin | 246 | $7,464 | $30 |
| Losartan | 471 | $7,064 | $15 |
| Ranolazine Er | 50 | $6,883 | $138 |
| Amlodipine Besylate | 672 | $6,546 | $10 |
| Coreg Cr | 11 | $6,415 | $583 |
| Amiodarone | 106 | $5,592 | $53 |
| Flecainide Acetate | 87 | $5,350 | $61 |
| Valsartan-Hydrochlorothiazide | 92 | $4,724 | $51 |
| Nitroglycerin Patch | 42 | $3,965 | $94 |
| Olmesartan Medoxomil | 47 | $3,839 | $82 |
| Propranolol Hcl Er | 35 | $3,824 | $109 |
| Carvedilol | 268 | $3,802 | $14 |
| Metoprolol | 393 | $3,489 | $9 |
| Hydrochlorothiazide | 489 | $3,458 | $7 |
| Simvastatin | 349 | $3,005 | $9 |
| Clopidogrel | 195 | $2,898 | $15 |
| Irbesartan | 40 | $2,884 | $72 |
| Nitroglycerin | 66 | $2,870 | $43 |
| Losartan-Hydrochlorothiazide | 92 | $2,630 | $29 |
| Nifedipine Er | 28 | $2,604 | $93 |
| Midodrine | 27 | $2,548 | $94 |
| Lisinopril | 252 | $2,413 | $10 |
| Diltiazem 24hr Er (Cd) | 55 | $2,395 | $44 |
| Omega-3 Acid Ethyl Esters | 16 | $2,353 | $147 |
| Fenofibrate | 40 | $2,262 | $57 |
| Potassium Chloride | 76 | $2,051 | $27 |
| Atenolol | 162 | $1,863 | $12 |
| Cozaar | 12 | $1,797 | $150 |
| Warfarin | 124 | $1,577 | $13 |
| Olmesartan-Hydrochlorothiazide | 11 | $1,410 | $128 |
| Propafenone | 18 | $1,367 | $76 |
| Furosemide | 172 | $1,273 | $7 |
| Ramipril | 56 | $1,273 | $23 |
| Metolazone | 15 | $1,230 | $82 |
| Levothyroxine | 52 | $1,220 | $23 |
| Spironolactone | 81 | $1,102 | $14 |
| Bisoprolol-Hydrochlorothiazide | 38 | $1,096 | $29 |
| Pravastatin | 52 | $1,082 | $21 |
| Triamterene-Hydrochlorothiazid | 70 | $1,080 | $15 |
| Propranolol | 18 | $1,040 | $58 |
| Telmisartan | 11 | $985 | $90 |
| Digoxin | 26 | $913 | $35 |
| Bisoprolol | 44 | $744 | $17 |
| Doxazosin Mesylate | 22 | $682 | $31 |
| Bumetanide | 15 | $667 | $44 |
| Diltiazem | 15 | $664 | $44 |
| Allopurinol | 26 | $614 | $24 |
| Enalapril Maleate | 20 | $603 | $30 |
| Famotidine | 21 | $568 | $27 |
| Omeprazole | 33 | $536 | $16 |
| Escitalopram | 33 | $532 | $16 |
| Tamsulosin | 27 | $517 | $19 |
| Benazepril | 35 | $485 | $14 |
| Diltiazem 24hr Er | 12 | $475 | $40 |
| Fludrocortisone Acetate | 11 | $459 | $42 |
| Quinapril | 23 | $424 | $18 |
| Finasteride | 12 | $364 | $30 |
| Verapamil Er | 16 | $355 | $22 |
| Hydralazine | 13 | $312 | $24 |
| Alprazolam | 43 | $300 | $7 |
| Isosorbide Mononitrate Er | 24 | $276 | $11 |
| Sumatriptan | 12 | $224 | $19 |
| Zolpidem | 41 | $217 | $5 |
| Pantoprazole | 16 | $215 | $13 |
| Lisinopril-Hydrochlorothiazide | 20 | $213 | $11 |
| Clonidine | 19 | $204 | $11 |
| Montelukast | 12 | $202 | $17 |
| Metformin | 16 | $161 | $10 |
| Lovastatin | 20 | $151 | $8 |
| Fluoxetine | 22 | $118 | $5 |
| Meloxicam | 12 | $107 | $9 |
| Jantoven | 17 | $104 | $6 |
| Amoxicillin | 21 | $49 | $2 |
2020: 84 drugs
| Eliquis | 305 | $279,985 | $918 |
| Xarelto | 243 | $241,546 | $994 |
| Repatha Sureclick | 196 | $124,694 | $636 |
| Entresto | 28 | $35,178 | $1,256 |
| Brilinta | 61 | $32,367 | $531 |
| Ezetimibe | 268 | $24,979 | $93 |
| Bystolic | 59 | $23,523 | $399 |
| Multaq | 18 | $22,430 | $1,246 |
| Betapace | 12 | $20,819 | $1,735 |
| Vascepa | 36 | $18,167 | $505 |
| Metoprolol | 494 | $13,620 | $28 |
| Praluent | 18 | $12,856 | $714 |
| Lipitor | 15 | $9,988 | $666 |
| Rosuvastatin | 210 | $8,180 | $39 |
| Valsartan | 88 | $7,686 | $87 |
| Atorvastatin | 541 | $7,270 | $13 |
| Nexletol | 13 | $6,953 | $535 |
| Ranolazine Er | 37 | $6,845 | $185 |
| Losartan | 343 | $5,252 | $15 |
| Amlodipine Besylate | 633 | $5,182 | $8 |
| Losartan-Hydrochlorothiazide | 76 | $5,166 | $68 |
| Nitroglycerin Patch | 66 | $4,739 | $72 |
| Valsartan-Hydrochlorothiazide | 85 | $4,394 | $52 |
| Amiodarone | 73 | $4,238 | $58 |
| Olmesartan Medoxomil | 42 | $3,936 | $94 |
| Propranolol Hcl Er | 37 | $3,735 | $101 |
| Flecainide Acetate | 47 | $3,552 | $76 |
| Altace | 12 | $2,967 | $247 |
| Hydrochlorothiazide | 389 | $2,684 | $7 |
| Edarbyclor | 11 | $2,593 | $236 |
| Simvastatin | 310 | $2,518 | $8 |
| Carvedilol | 214 | $2,415 | $11 |
| Metoprolol | 331 | $2,214 | $7 |
| Irbesartan | 40 | $2,080 | $52 |
| Clopidogrel | 126 | $2,071 | $16 |
| Olmesartan-Hydrochlorothiazide | 19 | $2,051 | $108 |
| Lisinopril | 200 | $1,753 | $9 |
| Midodrine | 19 | $1,723 | $91 |
| Bisoprolol | 54 | $1,638 | $30 |
| Nitroglycerin | 41 | $1,629 | $40 |
| Omega-3 Acid Ethyl Esters | 16 | $1,517 | $95 |
| Diltiazem 24hr Er (Cd) | 40 | $1,433 | $36 |
| Potassium Chloride | 62 | $1,431 | $23 |
| Levothyroxine | 47 | $1,318 | $28 |
| Atenolol | 123 | $1,251 | $10 |
| Warfarin | 97 | $1,215 | $13 |
| Bisoprolol-Hydrochlorothiazide | 38 | $1,174 | $31 |
| Triamterene-Hydrochlorothiazid | 66 | $1,115 | $17 |
| Fenofibrate | 16 | $1,111 | $69 |
| Propafenone | 12 | $991 | $83 |
| Labetalol | 11 | $960 | $87 |
| Telmisartan | 11 | $938 | $85 |
| Nifedipine Er | 12 | $900 | $75 |
| Propranolol | 24 | $865 | $36 |
| Spironolactone | 66 | $818 | $12 |
| Synthroid | 11 | $818 | $74 |
| Furosemide | 141 | $761 | $5 |
| Tamsulosin | 32 | $725 | $23 |
| Digoxin | 12 | $634 | $53 |
| Omeprazole | 33 | $613 | $19 |
| Duloxetine | 11 | $598 | $54 |
| Metolazone | 11 | $477 | $43 |
| Allopurinol | 22 | $464 | $21 |
| Benazepril | 24 | $439 | $18 |
| Quinapril | 18 | $439 | $24 |
| Pravastatin | 23 | $431 | $19 |
| Montelukast | 13 | $428 | $33 |
| Diltiazem 24hr Er | 11 | $425 | $39 |
| Lovastatin | 21 | $398 | $19 |
| Diltiazem | 11 | $332 | $30 |
| Sumatriptan | 13 | $305 | $23 |
| Famotidine | 12 | $292 | $24 |
| Lisinopril-Hydrochlorothiazide | 14 | $273 | $19 |
| Escitalopram | 18 | $234 | $13 |
| Ramipril | 13 | $226 | $17 |
| Meloxicam | 11 | $212 | $19 |
| Isosorbide Mononitrate Er | 20 | $202 | $10 |
| Clonidine | 19 | $132 | $7 |
| Zolpidem | 20 | $124 | $6 |
| Pantoprazole | 13 | $108 | $8 |
| Metformin | 16 | $76 | $5 |
| Clonazepam | 11 | $48 | $4 |
| Alprazolam | 20 | $48 | $2 |
| Amoxicillin | 14 | $40 | $3 |
2019: 79 drugs
| Xarelto | 264 | $216,157 | $819 |
| Eliquis | 220 | $170,803 | $776 |
| Repatha Sureclick | 166 | $123,489 | $744 |
| Multaq | 29 | $44,879 | $1,548 |
| Bystolic | 64 | $23,008 | $360 |
| Ezetimibe | 265 | $21,833 | $82 |
| Betapace | 12 | $20,509 | $1,709 |
| Entresto | 14 | $20,070 | $1,434 |
| Brilinta | 36 | $18,174 | $505 |
| Ranexa | 20 | $15,558 | $778 |
| Metoprolol | 366 | $14,537 | $40 |
| Vascepa | 27 | $14,104 | $522 |
| Pradaxa | 14 | $12,677 | $905 |
| Rosuvastatin | 130 | $8,689 | $67 |
| Ranolazine Er | 25 | $8,311 | $332 |
| Atorvastatin | 457 | $7,264 | $16 |
| Amiodarone | 66 | $5,327 | $81 |
| Amlodipine Besylate | 547 | $5,309 | $10 |
| Losartan | 308 | $3,993 | $13 |
| Nitroglycerin Patch | 62 | $3,636 | $59 |
| Simvastatin | 303 | $3,607 | $12 |
| Olmesartan-Hydrochlorothiazide | 26 | $3,557 | $137 |
| Carvedilol | 219 | $2,909 | $13 |
| Valsartan-Hydrochlorothiazide | 72 | $2,902 | $40 |
| Flecainide Acetate | 40 | $2,863 | $72 |
| Valsartan | 59 | $2,781 | $47 |
| Propranolol Hcl Er | 21 | $2,765 | $132 |
| Altace | 12 | $2,598 | $216 |
| Hydrochlorothiazide | 329 | $2,586 | $8 |
| Clonidine | 16 | $2,292 | $143 |
| Metoprolol | 309 | $2,172 | $7 |
| Olmesartan Medoxomil | 42 | $2,150 | $51 |
| Nitroglycerin | 52 | $2,032 | $39 |
| Lisinopril | 225 | $2,014 | $9 |
| Eplerenone | 13 | $1,979 | $152 |
| Cozaar | 13 | $1,946 | $150 |
| Toprol Xl | 45 | $1,773 | $39 |
| Bisoprolol | 56 | $1,643 | $29 |
| Warfarin | 116 | $1,537 | $13 |
| Potassium Chloride | 62 | $1,472 | $24 |
| Irbesartan | 33 | $1,427 | $43 |
| Clopidogrel | 97 | $1,410 | $15 |
| Labetalol | 12 | $1,405 | $117 |
| Atenolol | 112 | $1,360 | $12 |
| Losartan-Hydrochlorothiazide | 77 | $1,219 | $16 |
| Triamterene-Hydrochlorothiazid | 70 | $1,138 | $16 |
| Synthroid | 16 | $1,121 | $70 |
| Diltiazem 24hr Er (Cd) | 24 | $1,092 | $45 |
| Propafenone | 11 | $1,064 | $97 |
| Fenofibrate | 26 | $1,025 | $39 |
| Propranolol | 30 | $957 | $32 |
| Telmisartan | 15 | $924 | $62 |
| Levothyroxine | 31 | $908 | $29 |
| Tamsulosin | 21 | $774 | $37 |
| Furosemide | 112 | $754 | $7 |
| Pravastatin | 24 | $714 | $30 |
| Digoxin | 13 | $703 | $54 |
| Sertraline | 18 | $671 | $37 |
| Bisoprolol-Hydrochlorothiazide | 25 | $668 | $27 |
| Allopurinol | 22 | $605 | $27 |
| Omeprazole | 35 | $548 | $16 |
| Fludrocortisone Acetate | 20 | $533 | $27 |
| Spironolactone | 54 | $502 | $9 |
| Benazepril | 38 | $485 | $13 |
| Escitalopram | 18 | $429 | $24 |
| Quinapril | 19 | $400 | $21 |
| Jantoven | 27 | $356 | $13 |
| Diltiazem | 21 | $347 | $17 |
| Lovastatin | 18 | $306 | $17 |
| Isosorbide Mononitrate Er | 13 | $241 | $19 |
| Alprazolam | 19 | $232 | $12 |
| Metformin | 21 | $229 | $11 |
| Lisinopril-Hydrochlorothiazide | 15 | $219 | $15 |
| Pantoprazole | 14 | $217 | $15 |
| Esomeprazole Magnesium | 11 | $209 | $19 |
| Sumatriptan | 12 | $184 | $15 |
| Clonidine | 17 | $154 | $9 |
| Zolpidem | 13 | $139 | $11 |
| Amoxicillin | 13 | $45 | $3 |
2018: 77 drugs
| Xarelto | 187 | $146,636 | $784 |
| Eliquis | 123 | $104,201 | $847 |
| Repatha Sureclick | 62 | $65,554 | $1,057 |
| Ranexa | 31 | $38,187 | $1,232 |
| Ezetimibe | 186 | $27,580 | $148 |
| Multaq | 26 | $25,862 | $995 |
| Bystolic | 49 | $18,017 | $368 |
| Entresto | 13 | $15,839 | $1,218 |
| Metoprolol | 316 | $12,484 | $40 |
| Brilinta | 28 | $12,206 | $436 |
| Vascepa | 22 | $10,989 | $499 |
| Atorvastatin | 389 | $6,882 | $18 |
| Amlodipine Besylate | 509 | $5,279 | $10 |
| Propranolol Hcl Er | 17 | $4,067 | $239 |
| Amiodarone | 57 | $3,778 | $66 |
| Celecoxib | 15 | $3,376 | $225 |
| Rosuvastatin | 87 | $3,266 | $38 |
| Simvastatin | 295 | $3,216 | $11 |
| Valsartan | 79 | $3,202 | $41 |
| Nitroglycerin Patch | 56 | $3,162 | $56 |
| Losartan | 252 | $3,093 | $12 |
| Carvedilol | 213 | $2,668 | $13 |
| Flecainide Acetate | 33 | $2,485 | $75 |
| Eplerenone | 13 | $2,440 | $188 |
| Olmesartan Medoxomil | 18 | $2,232 | $124 |
| Valsartan-Hydrochlorothiazide | 64 | $2,097 | $33 |
| Metoprolol | 258 | $2,079 | $8 |
| Hydrochlorothiazide | 285 | $1,998 | $7 |
| Potassium Chloride | 50 | $1,952 | $39 |
| Bisoprolol | 52 | $1,918 | $37 |
| Esomeprazole Magnesium | 18 | $1,867 | $104 |
| Lisinopril | 201 | $1,816 | $9 |
| Nitroglycerin | 40 | $1,794 | $45 |
| Clopidogrel | 103 | $1,710 | $17 |
| Toprol Xl | 43 | $1,637 | $38 |
| Warfarin | 106 | $1,585 | $15 |
| Fenofibrate | 28 | $1,232 | $44 |
| Triamterene-Hydrochlorothiazid | 70 | $1,223 | $17 |
| Propafenone | 11 | $1,087 | $99 |
| Atenolol | 117 | $1,076 | $9 |
| Synthroid | 17 | $1,050 | $62 |
| Propranolol | 26 | $998 | $38 |
| Cartia Xt | 13 | $947 | $73 |
| Diltiazem 24hr Er | 12 | $940 | $78 |
| Losartan-Hydrochlorothiazide | 58 | $852 | $15 |
| Allopurinol | 27 | $823 | $30 |
| Pravastatin | 25 | $813 | $33 |
| Levothyroxine | 28 | $806 | $29 |
| Sertraline | 17 | $799 | $47 |
| Digoxin | 12 | $768 | $64 |
| Irbesartan | 26 | $735 | $28 |
| Furosemide | 107 | $640 | $6 |
| Diltiazem 24hr Er (Cd) | 11 | $615 | $56 |
| Metolazone | 16 | $577 | $36 |
| Diltiazem | 21 | $560 | $27 |
| Bisoprolol-Hydrochlorothiazide | 29 | $529 | $18 |
| Doxazosin Mesylate | 15 | $528 | $35 |
| Tamsulosin | 17 | $500 | $29 |
| Famotidine | 16 | $459 | $29 |
| Pantoprazole | 17 | $443 | $26 |
| Spironolactone | 52 | $427 | $8 |
| Fludrocortisone Acetate | 14 | $419 | $30 |
| Lovastatin | 20 | $413 | $21 |
| Omeprazole | 26 | $405 | $16 |
| Alprazolam | 29 | $361 | $12 |
| Quinapril | 13 | $350 | $27 |
| Benazepril | 33 | $349 | $11 |
| Lisinopril-Hydrochlorothiazide | 15 | $299 | $20 |
| Escitalopram | 21 | $297 | $14 |
| Clonidine | 37 | $292 | $8 |
| Jantoven | 16 | $292 | $18 |
| Sotalol | 11 | $291 | $26 |
| Ramipril | 12 | $272 | $23 |
| Metformin | 31 | $181 | $6 |
| Sumatriptan | 11 | $136 | $12 |
| Citalopram Hbr | 12 | $65 | $5 |
| Meloxicam | 11 | $42 | $4 |
2017: 82 drugs
| Xarelto | 174 | $121,688 | $699 |
| Eliquis | 84 | $64,202 | $764 |
| Zetia | 74 | $51,238 | $692 |
| Ranexa | 34 | $38,829 | $1,142 |
| Bystolic | 66 | $22,241 | $337 |
| Repatha Sureclick | 17 | $20,514 | $1,207 |
| Betapace | 11 | $17,898 | $1,627 |
| Multaq | 15 | $15,057 | $1,004 |
| Ezetimibe | 52 | $14,520 | $279 |
| Pradaxa | 15 | $14,032 | $935 |
| Brilinta | 24 | $13,892 | $579 |
| Metoprolol | 289 | $11,779 | $41 |
| Effient | 15 | $8,937 | $596 |
| Coreg Cr | 15 | $8,434 | $562 |
| Coreg | 18 | $7,550 | $419 |
| Vascepa | 18 | $6,946 | $386 |
| Atorvastatin | 325 | $6,249 | $19 |
| Tekturna | 16 | $5,454 | $341 |
| Olmesartan Medoxomil | 19 | $4,201 | $221 |
| Amlodipine Besylate | 457 | $4,201 | $9 |
| Rosuvastatin | 59 | $3,864 | $65 |
| Propranolol Hcl Er | 20 | $3,846 | $192 |
| Valsartan | 82 | $3,636 | $44 |
| Clonidine | 13 | $3,435 | $264 |
| Esomeprazole Magnesium | 17 | $3,045 | $179 |
| Nitroglycerin Patch | 46 | $2,698 | $59 |
| Eplerenone | 15 | $2,642 | $176 |
| Clopidogrel | 113 | $2,463 | $22 |
| Simvastatin | 271 | $2,396 | $9 |
| Warfarin | 158 | $2,366 | $15 |
| Omega-3 Acid Ethyl Esters | 13 | $2,296 | $177 |
| Carvedilol | 179 | $2,256 | $13 |
| Flecainide Acetate | 43 | $2,180 | $51 |
| Losartan | 186 | $2,180 | $12 |
| Fenofibrate | 27 | $2,153 | $80 |
| Valsartan-Hydrochlorothiazide | 63 | $2,073 | $33 |
| Lisinopril | 211 | $1,876 | $9 |
| Nitroglycerin | 41 | $1,780 | $43 |
| Potassium Chloride | 68 | $1,734 | $25 |
| Hydrochlorothiazide | 233 | $1,635 | $7 |
| Olmesartan-Hydrochlorothiazide | 14 | $1,570 | $112 |
| Amiodarone | 36 | $1,488 | $41 |
| Digoxin | 21 | $1,389 | $66 |
| Metoprolol | 223 | $1,384 | $6 |
| Diltiazem 24hr Er | 36 | $1,379 | $38 |
| Bisoprolol | 39 | $1,374 | $35 |
| Synthroid | 22 | $1,349 | $61 |
| Propafenone | 13 | $1,173 | $90 |
| Triamterene-Hydrochlorothiazid | 63 | $1,163 | $18 |
| Furosemide | 163 | $1,162 | $7 |
| Levothyroxine | 38 | $1,081 | $28 |
| Propranolol | 15 | $1,030 | $69 |
| Atenolol | 124 | $1,000 | $8 |
| Toprol Xl | 28 | $935 | $33 |
| Losartan-Hydrochlorothiazide | 53 | $818 | $15 |
| Allopurinol | 22 | $757 | $34 |
| Isosorbide Mononitrate Er | 15 | $714 | $48 |
| Pravastatin | 19 | $674 | $35 |
| Spironolactone | 51 | $621 | $12 |
| Sertraline | 15 | $541 | $36 |
| Metolazone | 12 | $533 | $44 |
| Cartia Xt | 17 | $514 | $30 |
| Omeprazole | 25 | $482 | $19 |
| Tamsulosin | 16 | $465 | $29 |
| Quinapril | 12 | $426 | $35 |
| Fluoxetine | 12 | $425 | $35 |
| Irbesartan | 15 | $412 | $27 |
| Diltiazem | 15 | $362 | $24 |
| Zolpidem | 28 | $350 | $12 |
| Benazepril | 36 | $289 | $8 |
| Pantoprazole | 15 | $285 | $19 |
| Bisoprolol-Hydrochlorothiazide | 19 | $277 | $15 |
| Lovastatin | 15 | $273 | $18 |
| Escitalopram | 17 | $251 | $15 |
| Lisinopril-Hydrochlorothiazide | 15 | $231 | $15 |
| Temazepam | 12 | $225 | $19 |
| Alprazolam | 23 | $222 | $10 |
| Metformin | 31 | $191 | $6 |
| Famotidine | 14 | $138 | $10 |
| Clonidine | 18 | $102 | $6 |
| Citalopram Hbr | 11 | $56 | $5 |
| Lorazepam | 12 | $49 | $4 |
2016: 85 drugs
| Xarelto | 172 | $97,989 | $570 |
| Zetia | 117 | $71,082 | $608 |
| Ranexa | 40 | $31,653 | $791 |
| Eliquis | 37 | $25,118 | $679 |
| Repatha Sureclick | 22 | $24,253 | $1,102 |
| Multaq | 15 | $19,208 | $1,281 |
| Effient | 27 | $16,289 | $603 |
| Crestor | 39 | $16,193 | $415 |
| Metoprolol | 310 | $13,016 | $42 |
| Betapace | 12 | $12,595 | $1,050 |
| Coreg Cr | 26 | $12,069 | $464 |
| Benicar | 24 | $11,415 | $476 |
| Pradaxa | 15 | $11,205 | $747 |
| Bystolic | 39 | $11,200 | $287 |
| Vytorin | 22 | $7,901 | $359 |
| Brilinta | 22 | $7,844 | $357 |
| Vascepa | 23 | $7,665 | $333 |
| Atorvastatin | 338 | $6,792 | $20 |
| Valsartan | 62 | $6,740 | $109 |
| Lyrica | 15 | $5,238 | $349 |
| Propranolol Hcl Er | 32 | $4,843 | $151 |
| Coreg | 16 | $4,650 | $291 |
| Tekturna | 22 | $4,553 | $207 |
| Amlodipine Besylate | 394 | $3,591 | $9 |
| Clonidine | 17 | $2,966 | $174 |
| Celecoxib | 17 | $2,951 | $174 |
| Diltiazem 24hr Er | 38 | $2,732 | $72 |
| Valsartan-Hydrochlorothiazide | 68 | $2,546 | $37 |
| Clopidogrel | 99 | $2,528 | $26 |
| Simvastatin | 294 | $2,518 | $9 |
| Carvedilol | 169 | $2,400 | $14 |
| Omega-3 Acid Ethyl Esters | 13 | $2,332 | $179 |
| Warfarin | 162 | $2,250 | $14 |
| Altace | 13 | $2,142 | $165 |
| Potassium Chloride | 64 | $1,992 | $31 |
| Synthroid | 30 | $1,871 | $62 |
| Cozaar | 13 | $1,857 | $143 |
| Digoxin | 38 | $1,839 | $48 |
| Lisinopril | 206 | $1,782 | $9 |
| Bisoprolol | 48 | $1,759 | $37 |
| Losartan | 165 | $1,739 | $11 |
| Amiodarone | 24 | $1,677 | $70 |
| Nitrostat | 29 | $1,541 | $53 |
| Metoprolol | 172 | $1,502 | $9 |
| Nitroglycerin Patch | 39 | $1,439 | $37 |
| Hydrochlorothiazide | 218 | $1,296 | $6 |
| Levothyroxine | 51 | $1,290 | $25 |
| Triamterene-Hydrochlorothiazid | 76 | $1,158 | $15 |
| Flecainide Acetate | 33 | $1,117 | $34 |
| Midodrine | 14 | $1,096 | $78 |
| Atenolol | 136 | $1,092 | $8 |
| Toprol Xl | 27 | $993 | $37 |
| Losartan-Hydrochlorothiazide | 69 | $984 | $14 |
| Allopurinol | 25 | $975 | $39 |
| Propafenone | 13 | $882 | $68 |
| Fenofibrate | 20 | $811 | $41 |
| Furosemide | 143 | $809 | $6 |
| Fludrocortisone Acetate | 17 | $788 | $46 |
| Pravastatin | 19 | $784 | $41 |
| Tamsulosin | 16 | $630 | $39 |
| Nitroglycerin | 11 | $614 | $56 |
| Zolpidem | 36 | $577 | $16 |
| Quinapril | 13 | $531 | $41 |
| Diltiazem 24hr Cd | 16 | $522 | $33 |
| Telmisartan | 11 | $467 | $42 |
| Spironolactone | 39 | $466 | $12 |
| Taztia Xt | 11 | $376 | $34 |
| Benazepril | 39 | $372 | $10 |
| Omeprazole | 22 | $362 | $16 |
| Alprazolam | 35 | $355 | $10 |
| Jantoven | 18 | $354 | $20 |
| Escitalopram | 23 | $328 | $14 |
| Irbesartan | 12 | $324 | $27 |
| Lovastatin | 15 | $320 | $21 |
| Famotidine | 24 | $319 | $13 |
| Pantoprazole | 17 | $319 | $19 |
| Clonidine | 30 | $286 | $10 |
| Lisinopril-Hydrochlorothiazide | 23 | $282 | $12 |
| Bisoprolol-Hydrochlorothiazide | 21 | $274 | $13 |
| Temazepam | 12 | $224 | $19 |
| Montelukast | 12 | $162 | $14 |
| Metformin | 30 | $147 | $5 |
| Finasteride | 13 | $135 | $10 |
| Azithromycin | 14 | $100 | $7 |
| Lorazepam | 15 | $79 | $5 |
2015: 75 drugs
| Xarelto | 129 | $67,927 | $527 |
| Zetia | 143 | $61,694 | $431 |
| Pradaxa | 47 | $27,008 | $575 |
| Ranexa | 41 | $26,692 | $651 |
| Crestor | 44 | $20,504 | $466 |
| Effient | 20 | $14,955 | $748 |
| Metoprolol | 294 | $13,941 | $47 |
| Valsartan | 57 | $10,058 | $176 |
| Multaq | 14 | $9,663 | $690 |
| Betapace | 11 | $8,958 | $814 |
| Benicar | 21 | $8,355 | $398 |
| Vytorin | 29 | $7,830 | $270 |
| Lovaza | 18 | $6,883 | $382 |
| Nexium | 19 | $6,881 | $362 |
| Coreg Cr | 18 | $6,053 | $336 |
| Bystolic | 35 | $6,038 | $173 |
| Brilinta | 19 | $5,919 | $312 |
| Atorvastatin | 286 | $5,635 | $20 |
| Propranolol Hcl Er | 20 | $4,492 | $225 |
| Tekturna | 16 | $4,140 | $259 |
| Vascepa | 18 | $3,987 | $222 |
| Valsartan-Hydrochlorothiazide | 82 | $3,825 | $47 |
| Warfarin | 217 | $3,502 | $16 |
| Coreg | 15 | $3,087 | $206 |
| Amlodipine Besylate | 288 | $2,347 | $8 |
| Atacand | 11 | $2,158 | $196 |
| Simvastatin | 272 | $2,052 | $8 |
| Toprol Xl | 29 | $1,951 | $67 |
| Bisoprolol | 56 | $1,916 | $34 |
| Digoxin | 43 | $1,800 | $42 |
| Carvedilol | 137 | $1,756 | $13 |
| Clopidogrel | 83 | $1,738 | $21 |
| Altace | 12 | $1,672 | $139 |
| Telmisartan | 11 | $1,659 | $151 |
| Pravastatin | 44 | $1,651 | $38 |
| Cozaar | 12 | $1,620 | $135 |
| Nitroglycerin Patch | 45 | $1,570 | $35 |
| Synthroid | 25 | $1,495 | $60 |
| Losartan | 157 | $1,490 | $9 |
| Diltiazem 24hr Er | 12 | $1,477 | $123 |
| Hydrochlorothiazide | 175 | $1,403 | $8 |
| Potassium Chloride | 36 | $1,366 | $38 |
| Lisinopril | 168 | $1,287 | $8 |
| Triamterene-Hydrochlorothiazid | 80 | $1,231 | $15 |
| Levothyroxine | 53 | $1,113 | $21 |
| Losartan-Hydrochlorothiazide | 77 | $1,104 | $14 |
| Digox | 15 | $1,041 | $69 |
| Diltiazem 24hr Cd | 26 | $1,009 | $39 |
| Allopurinol | 27 | $994 | $37 |
| Flecainide Acetate | 21 | $978 | $47 |
| Metoprolol | 109 | $930 | $9 |
| Nitrostat | 31 | $909 | $29 |
| Atenolol | 111 | $811 | $7 |
| Tamsulosin | 18 | $622 | $35 |
| Amiodarone | 20 | $617 | $31 |
| Propafenone | 15 | $576 | $38 |
| Taztia Xt | 16 | $534 | $33 |
| Bisoprolol-Hydrochlorothiazide | 30 | $476 | $16 |
| Furosemide | 68 | $433 | $6 |
| Zolpidem | 28 | $432 | $15 |
| Diltiazem | 15 | $382 | $25 |
| Benazepril | 35 | $310 | $9 |
| Pantoprazole | 12 | $300 | $25 |
| Escitalopram | 17 | $269 | $16 |
| Sertraline | 12 | $261 | $22 |
| Lovastatin | 17 | $260 | $15 |
| Omeprazole | 12 | $250 | $21 |
| Pioglitazone | 11 | $236 | $21 |
| Spironolactone | 19 | $211 | $11 |
| Lisinopril-Hydrochlorothiazide | 24 | $184 | $8 |
| Metformin | 21 | $180 | $9 |
| Alprazolam | 26 | $176 | $7 |
| Clonidine | 26 | $103 | $4 |
| Montelukast | 12 | $83 | $7 |
| Azithromycin | 12 | $82 | $7 |
2014: 73 drugs
| Xarelto | 109 | $53,685 | $493 |
| Zetia | 141 | $51,383 | $364 |
| Pradaxa | 68 | $27,678 | $407 |
| Ranexa | 43 | $21,062 | $490 |
| Diovan | 52 | $15,236 | $293 |
| Crestor | 47 | $14,623 | $311 |
| Multaq | 23 | $13,118 | $570 |
| Metoprolol | 211 | $11,625 | $55 |
| Benicar | 30 | $9,621 | $321 |
| Nexium | 17 | $8,552 | $503 |
| Vytorin | 30 | $6,487 | $216 |
| Lovaza | 16 | $6,109 | $382 |
| Valsartan-Hydrochlorothiazide | 72 | $5,260 | $73 |
| Atorvastatin | 233 | $5,078 | $22 |
| Celebrex | 16 | $4,811 | $301 |
| Coreg Cr | 14 | $4,644 | $332 |
| Fenofibrate | 15 | $4,173 | $278 |
| Valsartan | 19 | $3,752 | $197 |
| Propranolol Hcl Er | 21 | $3,382 | $161 |
| Amlodipine Besylate | 268 | $3,256 | $12 |
| Tekturna | 18 | $2,916 | $162 |
| Warfarin | 272 | $2,776 | $10 |
| Nisoldipine | 12 | $2,462 | $205 |
| Bisoprolol | 56 | $2,228 | $40 |
| Simvastatin | 222 | $2,221 | $10 |
| Bystolic | 14 | $2,189 | $156 |
| Carvedilol | 152 | $2,179 | $14 |
| Digox | 43 | $2,051 | $48 |
| Clopidogrel | 80 | $2,000 | $25 |
| Digoxin | 38 | $1,911 | $50 |
| Cozaar | 13 | $1,826 | $140 |
| Losartan | 151 | $1,794 | $12 |
| Toprol Xl | 24 | $1,636 | $68 |
| Altace | 12 | $1,471 | $123 |
| Hydrochlorothiazide | 158 | $1,440 | $9 |
| Synthroid | 18 | $1,431 | $80 |
| Losartan-Hydrochlorothiazide | 81 | $1,402 | $17 |
| Levothyroxine | 65 | $1,401 | $22 |
| Lisinopril | 174 | $1,331 | $8 |
| Norvasc | 12 | $1,226 | $102 |
| Potassium Chloride | 30 | $1,222 | $41 |
| Triamterene-Hydrochlorothiazid | 67 | $1,186 | $18 |
| Amiodarone | 19 | $1,093 | $58 |
| Nitroglycerin Patch | 30 | $1,086 | $36 |
| Pravastatin | 30 | $1,077 | $36 |
| Atenolol | 122 | $1,072 | $9 |
| Metoprolol | 102 | $967 | $9 |
| Antara | 12 | $915 | $76 |
| Omeprazole | 20 | $817 | $41 |
| Taztia Xt | 13 | $735 | $57 |
| Pioglitazone | 13 | $718 | $55 |
| Diltiazem 24hr Cd | 11 | $593 | $54 |
| Furosemide | 91 | $578 | $6 |
| Propafenone | 27 | $558 | $21 |
| Tamsulosin | 18 | $490 | $27 |
| Nitrostat | 22 | $455 | $21 |
| Benazepril | 33 | $422 | $13 |
| Spironolactone | 38 | $412 | $11 |
| Lovastatin | 19 | $322 | $17 |
| Escitalopram | 13 | $309 | $24 |
| Allopurinol | 18 | $307 | $17 |
| Zolpidem | 39 | $269 | $7 |
| Metformin | 20 | $263 | $13 |
| Bisoprolol-Hydrochlorothiazide | 26 | $238 | $9 |
| Acebutolol | 14 | $205 | $15 |
| Propranolol | 16 | $186 | $12 |
| Klor-Con 10 | 12 | $177 | $15 |
| Lisinopril-Hydrochlorothiazide | 14 | $167 | $12 |
| Alprazolam | 18 | $157 | $9 |
| Glyburide | 14 | $137 | $10 |
| Clonidine | 20 | $132 | $7 |
| Azithromycin | 17 | $122 | $7 |
| Montelukast | 12 | $122 | $10 |
2013: 68 drugs
| Zetia | 165 | $48,969 | $297 |
| Xarelto | 71 | $30,127 | $424 |
| Pradaxa | 74 | $29,045 | $392 |
| Diovan | 64 | $15,288 | $239 |
| Crestor | 47 | $11,273 | $240 |
| Metoprolol | 169 | $9,112 | $54 |
| Atorvastatin | 251 | $8,674 | $35 |
| Nexium | 21 | $8,297 | $395 |
| Multaq | 16 | $7,874 | $492 |
| Benicar | 28 | $7,721 | $276 |
| Lovaza | 32 | $7,699 | $241 |
| Ranexa | 18 | $7,153 | $397 |
| Effient | 11 | $6,992 | $636 |
| Valsartan-Hydrochlorothiazide | 61 | $5,635 | $92 |
| Clopidogrel | 84 | $5,094 | $61 |
| Hectorol | 13 | $4,545 | $350 |
| Lipitor | 11 | $4,358 | $396 |
| Vytorin | 19 | $4,331 | $228 |
| Diovan Hct | 13 | $3,990 | $307 |
| Amlodipine Besylate | 232 | $3,761 | $16 |
| Celebrex | 17 | $3,521 | $207 |
| Simvastatin | 248 | $3,239 | $13 |
| Tekturna | 15 | $2,953 | $197 |
| Warfarin | 260 | $2,921 | $11 |
| Losartan | 147 | $2,774 | $19 |
| Nisoldipine | 12 | $2,286 | $191 |
| Bisoprolol | 45 | $2,278 | $51 |
| Carvedilol | 130 | $2,213 | $17 |
| Propranolol | 33 | $2,206 | $67 |
| Toprol Xl | 27 | $1,761 | $65 |
| Bystolic | 11 | $1,732 | $157 |
| Hydrochlorothiazide | 160 | $1,707 | $11 |
| Lisinopril | 190 | $1,608 | $8 |
| Synthroid | 23 | $1,523 | $66 |
| Losartan-Hydrochlorothiazide | 89 | $1,521 | $17 |
| Propafenone | 23 | $1,395 | $61 |
| Metoprolol | 95 | $1,379 | $15 |
| Cozaar | 12 | $1,377 | $115 |
| Altace | 12 | $1,291 | $108 |
| Escitalopram | 18 | $1,264 | $70 |
| Atenolol | 125 | $1,223 | $10 |
| Potassium Chloride | 32 | $1,188 | $37 |
| Levothyroxine | 73 | $1,068 | $15 |
| Nitroglycerin Patch | 26 | $977 | $38 |
| Norvasc | 11 | $973 | $88 |
| Pioglitazone | 12 | $916 | $76 |
| Digox | 71 | $835 | $12 |
| Triamterene-Hctz | 48 | $763 | $16 |
| Amiodarone | 23 | $758 | $33 |
| Furosemide | 103 | $727 | $7 |
| Pantoprazole | 23 | $655 | $28 |
| Omeprazole | 16 | $653 | $41 |
| Pravastatin | 17 | $573 | $34 |
| Spironolactone | 41 | $457 | $11 |
| Nitrostat | 28 | $424 | $15 |
| Metformin | 21 | $356 | $17 |
| Lisinopril-Hydrochlorothiazide | 32 | $352 | $11 |
| Benazepril | 29 | $351 | $12 |
| Ramipril | 12 | $347 | $29 |
| Lovastatin | 13 | $318 | $24 |
| Bisoprolol-Hydrochlorothiazide | 27 | $278 | $10 |
| Montelukast | 12 | $254 | $21 |
| Acebutolol | 16 | $252 | $16 |
| Digoxin | 13 | $231 | $18 |
| Zolpidem | 31 | $229 | $7 |
| Allopurinol | 14 | $179 | $13 |
| Alprazolam | 34 | $131 | $4 |
| Clonidine | 14 | $93 | $7 |
Money from drug and device companies
$1,507 in 2025
| 2025 | 13 | 58 | None | $1,507 |
| 2024 | 18 | 108 | None | $1,696 |
| 2023 | 24 | 96 | None | $1,844 |
| 2022 | 24 | 125 | None | $2,166 |
| 2021 | 25 | 146 | None | $2,256 |
| 2020 | 22 | 107 | None | $1,700 |
| 2019 | 20 | 102 | None | $1,700 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Impulse Dynamics (USA) | Optimizer | $286 | 2 payments
|
| Medtronic | Affera Mapping System | $216 | 12 payments
|
| Novartis Pharmaceuticals | Leqvio | $197 | 12 payments
|
| Merck Sharp & Dohme | Verquvo | $174 | 6 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $143 | 8 payments
|
| Boston Scientific | Bodyguardian | $106 | 3 payments
|
See all 58 published payments
| Medtronic | Meals · 2025-12-23 | Affera Mapping System | $16 |
| Cleerly | Meals · 2025-12-15 | Cleerly Ischemia | $100 |
| Medtronic | Meals · 2025-12-11 | Affera Mapping System | $19 |
| Medtronic | Meals · 2025-12-04 | Affera Mapping System | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-20 | Camzyos | $19 |
| Medtronic | Meals · 2025-11-20 | Affera Mapping System | $14 |
| Medtronic | Meals · 2025-11-07 | Affera Mapping System | $20 |
| Novartis Pharmaceuticals | Meals · 2025-10-31 | Leqvio | $22 |
| Medtronic | Meals · 2025-10-31 | Affera Mapping System | $18 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-27 | Camzyos | $18 |
| Medtronic | Meals · 2025-10-23 | Affera Mapping System | $19 |
| Novartis Pharmaceuticals | Meals · 2025-10-21 | Leqvio | $24 |
| Novartis Pharmaceuticals | Meals · 2025-10-21 | Leqvio | $0 |
| Medtronic | Meals · 2025-10-14 | Affera Mapping System | $18 |
| Novartis Pharmaceuticals | Meals · 2025-10-10 | Leqvio | $15 |
| Merck Sharp & Dohme | Meals · 2025-09-30 | Verquvo | $27 |
| Novartis Pharmaceuticals | Meals · 2025-09-22 | Leqvio | $29 |
| Medtronic | Meals · 2025-09-18 | Affera Mapping System | $22 |
| Medtronic | Meals · 2025-09-10 | Affera Mapping System | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-28 | Eliquis | $19 |
| Novartis Pharmaceuticals | Meals · 2025-08-27 | Leqvio | $4 |
| Merck Sharp & Dohme | Meals · 2025-08-25 | Verquvo | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-20 | Camzyos | $16 |
| Novartis Pharmaceuticals | Meals · 2025-08-15 | Leqvio | $10 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-13 | Farxiga | $16 |
| Novartis Pharmaceuticals | Meals · 2025-07-30 | Leqvio | $24 |
| Boston Scientific | Meals · 2025-07-24 | Bodyguardian | $37 |
| Pfizer | Meals · 2025-07-15 | Vyndaqel | $22 |
| Impulse Dynamics (USA) | Meals · 2025-06-25 | Optimizer | $140 |
| Biotronik | Meals · 2025-06-24 | Amvia Edge | $15 |
| Novartis Pharmaceuticals | Meals · 2025-06-20 | Leqvio | $16 |
| Merck Sharp & Dohme | Meals · 2025-06-09 | Verquvo | $29 |
| Amgen | Meals · 2025-06-04 | Repatha | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-28 | Camzyos | $17 |
| Novartis Pharmaceuticals | Meals · 2025-05-21 | Leqvio | $20 |
| Novo Nordisk | Meals · 2025-05-12 | Wegovy | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-01 | Farxiga | $14 |
| AltaThera Pharmaceuticals | Meals · 2025-04-29 | Sotalol Hydrochloride | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-22 | Camzyos | $19 |
| Medtronic | Meals · 2025-04-16 | Mycarelink | $10 |
| Medtronic | Meals · 2025-04-16 | Affera Mapping System | $20 |
| Novartis Pharmaceuticals | Meals · 2025-04-11 | Leqvio | $18 |
| Biotronik | Meals · 2025-04-02 | Biomonitor | $24 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-01 | Eliquis | $18 |
| Impulse Dynamics (USA) | Meals · 2025-03-19 | Optimizer | $147 |
| Pfizer | Meals · 2025-03-14 | Vyndaqel | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-13 | Farxiga | $15 |
| Merck Sharp & Dohme | Meals · 2025-03-12 | Verquvo | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-11 | Camzyos | $17 |
| Boston Scientific | Meals · 2025-02-26 | Watchman Access System | $39 |
| Novartis Pharmaceuticals | Meals · 2025-02-24 | Leqvio | $15 |
| Pfizer | Meals · 2025-02-24 | Vyndaqel | $21 |
| Merck Sharp & Dohme | Meals · 2025-02-19 | Verquvo | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-12 | Wainua | $20 |
| Biotronik | Meals · 2025-02-12 | Amvia Edge | $24 |
| Boston Scientific | Meals · 2025-01-23 | Bodyguardian | $30 |
| Pfizer | Meals · 2025-01-07 | Vyndaqel | $25 |
| Merck Sharp & Dohme | Meals · 2025-01-07 | Verquvo | $33 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,696
| Merck Sharp & Dohme | Verquvo | $251 | 9 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $229 | 14 payments
|
| Amgen | Repatha | $191 | 11 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $180 | 10 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $163 | 10 payments
|
| Pfizer | Vyndaqel | $155 | 22 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $98 | 6 payments
|
| Novartis Pharmaceuticals | Leqvio | $66 | 4 payments
|
| Novo Nordisk | Ozempic | $64 | 3 payments
|
| Biotronik | Biomonitor | $63 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $52 | 2 payments
|
| Medtronic | Azure Xt Dr Mri Surescan | $45 | 2 payments
|
| Lexicon Pharmaceuticals | None | $29 | 1 payment
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $27 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $23 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $23 | 1 payment
|
| Actelion Pharmaceuticals US | Uptravi | $22 | 1 payment
|
| Esperion Therapeutics | Nexletol | $14 | 1 payment
|
2023: $1,844
| AstraZeneca Pharmaceuticals LP | Farxiga | $225 | 13 payments
|
| Amgen | Repatha | $200 | 13 payments
|
| Novartis Pharmaceuticals | Leqvio | $177 | 9 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $150 | 11 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $116 | 5 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $111 | 4 payments
|
| Medtronic | Corevalve Evolut R | $94 | 2 payments
|
| Boston Scientific | Watchman Access System | $86 | 4 payments
|
| Itamar Medical | Watchpatone | $80 | 1 payment
|
| Esperion Therapeutics | Nexletol | $77 | 4 payments
|
| Amarin Pharma | Vascepa | $69 | 3 payments
|
| Biotronik | Biomonitor | $69 | 3 payments
|
| Novo Nordisk | Rybelsus | $67 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $53 | 4 payments
|
| Tactile Systems Technology | Flexitouch Plus | $45 | 2 payments
|
| iRhythm Technologies | Zio Xt Patch | $44 | 2 payments
|
| Pfizer | Eliquis | $42 | 2 payments
|
| Abbott Laboratories | Mitraclip | $27 | 1 payment
|
| Regeneron Healthcare Solutions | Evkeeza | $25 | 1 payment
|
| CVRx | Barostim Neo System | $21 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $19 | 1 payment
|
| Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor | $15 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $15 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $14 | 1 payment
|
2022: $2,166
| Amgen | Repatha | $303 | 15 payments
|
| Novartis Pharmaceuticals | Entresto | $252 | 14 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $233 | 17 payments
|
| Boston Scientific | General - Therapies | $176 | 8 payments
|
| Novo Nordisk | Rybelsus | $152 | 10 payments
|
| Amarin Pharma | Vascepa | $145 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $135 | 9 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $125 | 6 payments
|
| Janssen Pharmaceuticals | Xarelto | $125 | 8 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $97 | 5 payments
|
| Esperion Therapeutics | Nexletol | $58 | 3 payments
|
| Medtronic | Azure Xt Dr Mri Surescan | $50 | 2 payments
|
| Pfizer | Eliquis | $40 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $39 | 4 payments
|
| HeartFlow | Ffrct | $36 | 2 payments
|
| Alnylam Pharmaceuticals | Onpattro | $28 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $27 | 1 payment
|
| Kestra Medical Technology Services | Assure Wcd | $24 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $24 | 1 payment
|
| Itamar Medical | Watchpat | $24 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $22 | 1 payment
|
| Biotronik | Edora 8 Dr-T | $20 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $17 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $12 | 1 payment
|
2021: $2,256
| Novartis Pharmaceuticals | Entresto | $269 | 25 payments
|
| Amarin Pharma | Vascepa | $233 | 10 payments
|
| Amgen | Repatha | $205 | 11 payments
|
| Esperion Therapeutics | Nexletol | $194 | 11 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $152 | 8 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $140 | 9 payments
|
| Merck Sharp & Dohme | Verquvo | $130 | 7 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $130 | 11 payments
|
| Novo Nordisk | Ozempic | $120 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $112 | 6 payments
|
| Janssen Pharmaceuticals | Xarelto | $95 | 10 payments
|
| Medtronic | Micra | $92 | 5 payments
|
| Sanofi-Aventis U.S. | Multaq | $61 | 3 payments
|
| Kowa Pharmaceuticals America | Livalo | $59 | 3 payments
|
| Boston Scientific | Watchman | $46 | 2 payments
|
| Actelion Pharmaceuticals US | Uptravi | $42 | 3 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $32 | 1 payment
|
| Abbott Laboratories | Mitraclip System | $22 | 1 payment
|
| iRhythm Technologies | Zio Patch | $21 | 1 payment
|
| Biosense Webster | Carto 3 | $20 | 1 payment
|
| Kiniksa Pharmaceuticals | None | $18 | 1 payment
|
| Currax Pharmaceuticals | Contrave | $18 | 1 payment
|
| Arbor Pharmaceuticals | Horizant | $17 | 1 payment
|
| Amryt Pharma Holdings | Juxtapid | $15 | 1 payment
|
| Pfizer | Eliquis | $13 | 1 payment
|
2020: $1,700
| Amgen | Corlanor | $265 | 13 payments
|
| Amarin Pharma | Vascepa | $211 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $199 | 13 payments
|
| Novartis Pharmaceuticals | Entresto | $166 | 14 payments
|
| Abbott Laboratories | Mitra Clip System | $126 | 3 payments
|
| Sanofi-Aventis U.S. | Multaq | $107 | 5 payments
|
| Janssen Pharmaceuticals | Xarelto | $102 | 10 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $64 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $58 | 7 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $57 | 3 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $56 | 2 payments
|
| Esperion Therapeutics | Nexletol | $51 | 3 payments
|
| Boston Scientific | Watchman | $43 | 2 payments
|
| Medtronic Vascular | Micra | $39 | 3 payments
|
| Arbor Pharmaceuticals | Edarbi | $32 | 2 payments
|
| Kowa Pharmaceuticals America | Livalo | $28 | 2 payments
|
| Relypsa | Veltassa | $21 | 1 payment
|
| Astellas Pharma US | Lexiscan | $17 | 1 payment
|
| AngioDynamics | None | $17 | 1 payment
|
| Actelion Pharmaceuticals US | Uptravi | $16 | 1 payment
|
| Tactile Systems Technology | Flexitouch | $15 | 1 payment
|
| Novo Nordisk | Saxenda | $11 | 1 payment
|
2019: $1,700
| Amgen | Corlanor | $352 | 17 payments
|
| Amarin Pharma | Vascepa | $202 | 10 payments
|
| Novartis Pharmaceuticals | Entresto | $151 | 15 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $149 | 10 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $138 | 4 payments
|
| Sanofi-Aventis U.S. | Multaq | $121 | 7 payments
|
| Gilead Sciences | None | $113 | 14 payments
|
| Abbott Laboratories | Confirm Rx | $85 | 2 payments
|
| Medtronic Vascular | Claria Mri | $72 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $70 | 4 payments
|
| Lundbeck | Northera | $46 | 2 payments
|
| Arbor Pharmaceuticals | Horizant | $41 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $39 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $28 | 2 payments
|
| Portola Pharmaceuticals | Andexxa | $20 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $19 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $18 | 1 payment
|
| Actelion Pharmaceuticals US | Uptravi | $15 | 1 payment
|
| Tactile Systems Technology | Flexitouch | $14 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $6 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Medtronic, Inc. · Expand II · 2023 | Their institution | $4,775 |
| Medtronic, Inc. · Expand II · 2024 | Their institution | $1,589 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1962404723
- Licence
- CA G69896California G69896: Current · expires 2028-07-31
- Trained
- University of California, Geffen School of Medicine, 1989 · 37 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G698960
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 2220 Lynn Rd, Suite 208, Thousand Oaks, CA, 91360
- NPI first listed
- 2005-08-11
- NPI last updated
- 2008-04-18
This is when the NPI record was last certified, not a medical board exam.